Hello new staff #6

Ying comes from Southern Medical University, Guangzhou, China and will do research about STEC, and her major is pathogenic biology. Ying's research direction during her PhD was the interaction between EHEC O157:H7 EspF protein and host proteins and its pathogenic mechanism.

Marion comes from Grenoble (France) and did her PhD at the University of Geneva (Switzerland). At Labmed she will work as a postdoc on HIV-specific T cell pathogenesis and immune exhaustion with a particular interest in immune recovery and health, in perinatally HIV-infected children and pregnant women.

Daniela comes from Salvador (Brazil) and did her PhD at the Federal University of Bahia (Brazil). At Labmed she will work as a postdoc on the screening of neoantigens targeting specific patients for tumor-specific T-cell receptors (TCR) of tumor-infiltrating T-cells (TILs).

During Jonas' PhD at Karolinska Institutet he studied how the p16 and p15 tumor suppressor genes regulate tumor-related transformation, replicative senescence and telomerase activity. At the end of his PhD, he initiated studies on the coxsackie- and adenovirus receptor (CAR) and cloned its homologue; CAR-like membrane protein (CLMP). After medical studies, he moved to University of California San Francisco (UCSF) for a 3-year postdoc. During this period, he used high-resolution imaging techniques to study cellular and molecular mechanisms of vascular remodeling in mouse models of chronic inflammation. Upon returning to Karolinska Institutet he established a research group with the aim to explore how inflammatory signals affect cell plasticity and tissue remodeling in inflammation and cancer. Over the years, they have discovered novel mechanisms of how tumor cells acquire invasive and metastatic properties by undergoing epithelial-mesenchymal transition (EMT). A major goal for the coming years is to establish collaborative research projects with clinical and research colleagues at KI Flemingsberg to explore EMT as a novel diagnostic tool and therapeutic target in cancer progression. 

Gosia comes from Lodz in Poland. She studied Biotechnology at the Lodz University of Technology in Poland where she received her Masters degree in Biotechnology with a major in Molecular Biotechnology and Technical Biochemistry. During her university studies she spent a semester at the Technical University of Denmark under the Erasmus framework. She then moved to Switzerland to perform my PhD at the Swiss Federal Institute of Technology, ETH, in Zurich. There, she have worked with the model organism Drosophila melanogaster to study genetics of tumorigenesis with a particular focus on the insulin and mTOR signaling pathway.  After obtaining her PhD, she joined the group of Prof Jonas Fuxe to study the role of epithelial-mesenchymal transition during lymph node metastasis.

Nikolina comes from Greece where she has studied for her Bachelor and her first Master degree in Biological Applications and Technologies, at University of Ioannina. After that she was granted a research fellowship for 2 years and worked as a Research Associate at a Biomedical Institute in Larisa, Greece. Then she moved to Sweden for her second Master degree which was in Biomedicine at Karolinska Institutet, and now she is a PhD student in Jonas Fuxe group where she studies the Lymphatic dissemination of EMT cancer cells.

Wenwen graduated from University of Lübeck and is a licensed physician in Germany. She got her doctorate at Institute of Physiology at University of Lübeck where she studied hypoxia signaling pathways in cancer cells. She joined the research group of Jonas Fuxe at MTC in August 2018 as a holder of DFG (Deutsche Forschungsgemeinschaft) research fellowship. Currently, she is working on identifying novel pathways involved in lymphatic metastasis of oral squamous cell carcinoma.

I do research in the field of onco-immunology and studying of cellular and molecular mechanisms of tissue remodeling in chronic inflammatory diseases such as diabetes and atherosclerosis and cancer metastasis.